華綠生物(300970.SZ)半年度淨利潤預降92.97%-100%
格隆匯7月14日丨華綠生物(300970.SZ)公佈,預計2021年半年度歸屬於上市公司股東的淨利潤0萬元-500萬元,同比下降92.97%-100%。業績變動原因如下:
1.報吿期內食用菌市場價格整體下行,導致公司產品銷售單價亦隨之下降較多。下表列示了2020年1-6月、2021年1-6月北京新發地農產品批發市場和浙江省金華農產品批發市場金針菇月度平均售價之情況:

數據來源:全國農產品商務信息公共服務平台(http://nc.mofcom.gov.cn/)
由上表,2021年1-6月市場價格較2020年1-6月有所下降,公司產品銷售的單位價格亦下降較多。
2.受國內外大環境影響,報吿期內食用菌生產原材料價格上漲較大,產品單位成本上升明顯。
以公司主要原材料米糠和麩皮為例,2021年1-6月,該等原材料的市場價格均增加較多,漲價幅度超過40%,公司採購價格由此也上漲較多,由此帶來了單位成本的大幅增加。

數據來源:wind資訊數據庫
由此,受銷售端和採購端市場環境的影響,公司2021年上半年預計業績有所下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.